TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| AstraZeneca Poaches R&D Head AstraZeneca hired a senior executive from rival Pfizer to head its drug research efforts, while Pfizer scrapped a short-lived experiment with having two heads of research. online.wsj.com |
Medtronic Spine Device Draws Concern The FDA expressed concern about a higher number of cancer cases seen among patients treated with a Medtronic spine device. online.wsj.com |
FDA Panel Backs Proposed Epilepsy Drug A Food and Drug Administration panel Wednesday backed a proposed epilepsy drug called Potiga developed by Valeant Pharmaceuticals International and GlaxoSmithKline PLC. online.wsj.com |
Study Backs Simpler CPR Technique People who suffered cardiac arrest and received chest compressions from bystanders had higher survival rates than those given standard resuscitation that included mouth-to-mouth breathing, a new study found. online.wsj.com |
3 Clear Winners of ESMO 2010 Ohad Hammer submits:The ESMO meeting is the most important oncology conference in Europe. This year in particular, it included very interesting data that affected the sentiment towards many biotech companies. Here, I intend to focus on what I view as three clear winners from the conference: Seattle Genetics (SGEN), Arqule (ARQL) and Dendreon (DNDN). Seattle GeneticsComplete Story » seekingalpha.com |